Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats

Endocrinology. 2009 Feb;150(2):1033-42. doi: 10.1210/en.2008-1112. Epub 2008 Oct 16.

Abstract

The time-dependent effects of mild hypothyroidism on endothelial function were assessed in rat mesenteric arteries. Male Wistar rats were treated with methimazole (MMI; 0.003%) or placebo up to 16 wk. Endothelial function of mesenteric small arteries was assessed by pressurized myograph. MMI-treated animals displayed a decrease in serum thyroid hormones, an increment of plasma TSH and inflammatory cytokines, and a blunted vascular relaxation to acetylcholine, as compared with controls. Endothelial dysfunction resulted from a reduced nitric oxide (NO) availability caused by oxidative excess. Vascular-inducible NO synthase (iNOS) expression was up-regulated. S-methylisothiourea (an iNOS inhibitor) normalized endothelium-dependent relaxations and restored NO availability in arteries from 8-wk MMI-animals and partly ameliorated these alterations in 16-wk MMI rats. Similar results were obtained when MMI-induced hypothyroidism was prevented by T(4) replacement. Among controls, an impaired NO availability, secondary to oxidative excess, occurred at 16 wk, and it was less pronounced than in age-matched MMI animals. Both endothelial dysfunction and oxidant excess secondary to aging were prevented by apocynin (nicotinamide adenine dinucleotide phosphate oxidase inhibitor). Mesenteric superoxide production was reduced by S-methylisothiourea and T(4) replacement in MMI animals and abolished by apocynin in controls (dihydroethidium staining). MMI-induced mild hypothyroidism is associated with endothelial dysfunction caused by a reduced NO availability, secondary to oxidative excess. It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of iNOS, resulting in superoxide generation, accounts for an impaired NO availability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allopurinol / pharmacology
  • Animals
  • Ascorbic Acid / pharmacology
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiopathology*
  • Enzyme Inhibitors / pharmacology
  • Hypothyroidism / chemically induced
  • Hypothyroidism / metabolism
  • Hypothyroidism / pathology
  • Hypothyroidism / physiopathology*
  • Male
  • Mesenteric Arteries / metabolism
  • Mesenteric Arteries / physiopathology*
  • Methimazole
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / physiology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide Synthase Type II / physiology*
  • Rats
  • Rats, Wistar
  • Superoxides / metabolism
  • Thyroxine / pharmacology
  • Vasodilation / drug effects

Substances

  • Enzyme Inhibitors
  • Superoxides
  • Nitric Oxide
  • Methimazole
  • Allopurinol
  • Nitric Oxide Synthase Type II
  • NADPH Oxidases
  • Ascorbic Acid
  • Thyroxine
  • NG-Nitroarginine Methyl Ester